In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Monohydrate, Cephalexin Drug Master File in Korea (Monohydrate, Cephalexin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Monohydrate, Cephalexin. The MFDS reviews the Monohydrate, Cephalexin KDMF as part of the drug registration process and uses the information provided in the Monohydrate, Cephalexin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Monohydrate, Cephalexin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Monohydrate, Cephalexin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Monohydrate, Cephalexin suppliers with KDMF on PharmaCompass.